Previous 10 | Next 10 |
This article is part of a series that provides an ongoing analysis of the changes made to Kahn Brothers' 13F stock portfolio on a quarterly basis. It is based on Kahn Brothers' regulatory 13F Form filed on 11/05/2019. Please visit our Tracking Kahn Brothers Portfolio series to get an idea ...
Image source: The Motley Fool. Hologic Inc (NASDAQ: HOLX) Q4 2019 Earnings Call Nov 6, 2019 , 4:30 p.m. ET Operator Continue reading
Hologic, Inc. (HOLX) Q4 2019 Results Conference Call November 06, 2019 04:30 PM ET Company Participants Mike Watts - Vice President of Investor Relations and Corporate Communications Steve MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financi...
Hologic (NASDAQ: HOLX ) fiscal Q4 results : More news on: Hologic, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Hologic (NASDAQ: HOLX ): Q4 Non-GAAP EPS of $0.65 in-line; GAAP EPS of $0.15 misses by $0.25 . Revenue of $865.8M (+9.4% Y/Y) beats by $19.26M . Press Release More news on: Hologic, Inc., Earnings news and commentary, Healthcare stocks news,
– Revenue of $865.8 Million Grows 6.4%, 7.3% in Constant Currency – – Company Posts GAAP Diluted EPS of $0.15 Due to Non-Cash Charges, Non-GAAP Diluted EPS of $0.65 – – Company Expects Solid Revenue and Non-GAAP EPS Growth in Fiscal 2020 – ...
Physicians can now access a wide variety of uterine cavities effortlessly with innovative SureAccess balloon technology Hologic, Inc. (Nasdaq: HOLX) has launched the Definity™ cervical dilator, a major advancement for gynecological procedures that uses SureAccess™ balloon...
Hologic points to hundreds of peer-reviewed clinical studies that consistently demonstrate improved outcomes with 3D mammography Hologic, Inc. (Nasdaq: HOLX) today objected to the October 24, 2019 USA Today article, “3D mammograms getting the hard sell,” and reaffirmed ...
MARLBOROUGH, Mass. , Oct. 14, 2019 /PRNewswire/ -- The Genius ™ 3D Mammography ™ exam (also known as the Genius™ exam) is only available on a Hologic® 3D Mammography™ system. The Genius ™ exam consists of a 2D and 3D ™...
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2019 on Wednesday, November 6, 2019, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eas...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...